Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Geron Corp (NASDAQ:GERN)

2.24
Delayed Data
As of Sep 25
 +0.08 / +3.70%
Today’s Change
1.81
Today|||52-Week Range
3.15
+8.21%
Year-to-Date
No recent news for Geron Corp.

Today’s Trading

Previous close2.16
Today’s open2.15
Day’s range2.15 - 2.25
Volume1,034,042
Average volume (3 months)1,148,502
Market cap$343.9M
Dividend yield--
Data as of 09/25/2017

Growth & Valuation

Earnings growth (last year)-63,433.33%
Earnings growth (this year)--
Earnings growth (next 5 years)--
Revenue growth (last year)-83.06%
P/E ratioNM
Price/Sales53.43
Price/Book2.81

Competitors

 Today’s
change
Today’s
% change
BTXBioTime Inc-0.08-2.86%
BLCMBellicum Pharmaceuti...+0.21+1.84%
EDGEEdge Therapeutics In...+0.13+1.36%
AGENAgenus Inc+0.03+0.73%
Data as of 09/25/2017

Financials

Next reporting dateNovember 9, 2017
EPS forecast (this quarter)-$0.05
Annual revenue (last year)$6.2M
Annual profit (last year)-$29.5M
Net profit margin-479.34%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
John A. Scarlett
Chief Financial Officer, Treasurer &
Executive VP
Olivia K. Bloom
Corporate headquarters
Menlo Park, California

Forecasts